Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a minor technical update to the page. This update does not alter the study details or visible content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew help and navigation sections were added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment label, along with a Revision: v3.6.0 tag. Older terms and sections, such as Verified, Last known status was:, Intervention / Treatment, Melanoma, related topics:, MedlinePlus Genetics, and Revision: v3.5.5, were removed.SummaryDifference2%

- Check23 days agoChange DetectedThis change updates the page revision from v3.5.4 to v3.5.5, representing a minor backend CMS update. It does not modify the study details or reported information.SummaryDifference0.1%

- Check30 days agoChange DetectedAdds a Melanoma entry and a related topics section listing MedlinePlus Genetics to the page, improving access to disease and genetics information.SummaryDifference0.2%

- Check45 days agoChange Detected- The page now includes a new revision label v3.5.4 in the revision history. The older revision v3.5.3 and related topics (Melanoma and MedlinePlus Genetics) were removed from the related topics list.SummaryDifference0.2%

- Check66 days agoChange DetectedThe page’s “related topics”/metadata area was updated (including the displayed revision/version). This reflects a non-substantive update to informational links rather than changes to the study record itself.SummaryDifference0.2%

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.